Routes of
administration By mouth CAS Number 1222102-29-5 ChemSpider 26339341 | ATC code None PubChem CID 25022354 UNII 09118300L7 | |
 | ||
Evogliptin (INN; trade name Suganon, previously identified as DA-1229) is an antidiabetic drug in the dipeptidyl peptidase-4 (DPP-4) inhibitor or "gliptin" class of drugs. It was developed by the South Korean pharmaceutical company Dong-A ST and is approved for use in South Korea.
References
Evogliptin Wikipedia(Text) CC BY-SA